Spinach and okra role in lowering blood sugar, weight, glucose and A1c their role in appetite hormone changes in obese women with type-2 diabetes - Trial IRCT20171205037760N1
Access comprehensive clinical trial information for IRCT20171205037760N1 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Kermanshah University of Medical Sciences and is currently Completed. The study focuses on Non-insulin-dependent diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20171205037760N1
Phase 2/3
Completed
other
Trial Details
Iranian Registry Of Clinical Trial • IRCT20171205037760N1
Spinach and okra role in lowering blood sugar, weight, glucose and A1c their role in appetite hormone changes in obese women with type-2 diabetes
The synergic study effect of Spinach and Okra on glucose, gerlin, introstatin and GLP-1 serum levels and the weight in obsess (BMI27) diabetic women
Study Focus
Sponsor & Location
Kermanshah University of Medical Sciences
Iran
Timeline & Enrollment
Phase 2/3
Dec 22, 2017
N/A
ICD-10 Classifications
Other specified diabetes mellitus without complications
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus
Other specified diabetes mellitus with other specified complications
Other specified diabetes mellitus with unspecified complications
Data Source
Iranian Registry Of Clinical Trial
IRCT20171205037760N1
Non-Device Trial